Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 37Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1

Conditions

Carcinoma, Renal Cell 17Kidney Neoplasms 3Gastrointestinal Stromal Tumors 3Neoplasms 2Financial Stress 2Carcinoma 2Urogenital Neoplasms 1Pancreatic Neuroendocrine Tumors 1Lymphoma, Mantle-Cell 1Kidney Diseases 1Hypertension 1Clear-cell metastatic renal cell carcinoma 1Adenoma, Islet Cell 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Neoplasms × Sunitinib × Clear all
NCT04033991 2023-04-06

Study of Patients With Metastatic and/or Advanced Renal Cell Carcinoma, Treated With Sunitinib/Axitinib.

Pfizer

Completed
684 enrolled 20 charts
Tumor-Agnostic

Carcinoma, Neoplasms

NCT00980213 2014-02-06

Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland

Tampere University Hospital

Completed
80 enrolled
Genitourinary

Carcinoma, Renal Cell, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡